Literature DB >> 10227714

Physical stability of ethyl diatrizoate nanocrystalline suspension in steam sterilization.

G C Na1, H J Stevens, B O Yuan, N Rajagopalan.   

Abstract

PURPOSE: To study the effects of formulation variables on the physical stability of a submicron crystal (nanocrystal) suspension under steam sterilization conditions.
METHODS: Suspensions of ethyl diatrizoate nanocrystals were prepared by wet milling in the presence of the surfactant poloxamine 908. Particle size distribution and zeta potential were measured by photon correlation spectroscopy.
RESULTS: On heating, the mean particle size of the nanocrystal suspension remained essentially unchanged up to 110 degrees C, the cloud point of the stabilizing surfactant, but increased significantly above that temperature. The increase in particle size was a result of particle aggregation rather than crystal growth. Adding a cloud point booster to the suspension significantly minimized the particle aggregation at high temperatures. The purity of poloxamine 908 and the tonicity agent and buffer salt used also affected the heat stability of the suspension, the latter agents apparently through altering the surfactant cloud point.
CONCLUSIONS: The aggregation of the ethyl diatrizoate nanocrystalline suspension under steam sterilization conditions was a result of phase separation of the stabilizing surfactant at its cloud point. When formulated with a cloud point booster to prevent the phase-separation, the suspension maintained its physical stability under steam sterilization without any significant change in particle size distribution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227714     DOI: 10.1023/a:1018883431970

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  2 in total

1.  Cloud point of nonionic surfactants: modulation with pharmaceutical excipients.

Authors:  G C Na; B O Yuan; H J Stevens; B S Weekley; N Rajagopalan
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

2.  Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs.

Authors:  E Merisko-Liversidge; P Sarpotdar; J Bruno; S Hajj; L Wei; N Peltier; J Rake; J M Shaw; S Pugh; L Polin; J Jones; T Corbett; E Cooper; G G Liversidge
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

  2 in total
  5 in total

1.  Cloud point of nonionic surfactants: modulation with pharmaceutical excipients.

Authors:  G C Na; B O Yuan; H J Stevens; B S Weekley; N Rajagopalan
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

2.  The preparation and evaluation of water-soluble SKLB610 nanosuspensions with improved bioavailability.

Authors:  Yunchuang Huang; Xun Luo; Xinyu You; Yong Xia; Xuejiao Song; Luoting Yu
Journal:  AAPS PharmSciTech       Date:  2013-08-10       Impact factor: 3.246

Review 3.  Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.

Authors:  William R Lykins; Ellen Luecke; Daniel Johengen; Ariane van der Straten; Tejal A Desai
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

4.  Understanding the structure and stability of paclitaxel nanocrystals.

Authors:  Jiexin Deng; Leaf Huang; Feng Liu
Journal:  Int J Pharm       Date:  2010-02-16       Impact factor: 5.875

5.  Smartcrystals for Efficient Dissolution of Poorly Water-Soluble Meloxicam.

Authors:  Rita Ambrus; Areen Alshweiat; Piroska Szabó-Révész; Csilla Bartos; Ildikó Csóka
Journal:  Pharmaceutics       Date:  2022-01-21       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.